Free Trial

Nisa Investment Advisors LLC Sells 85,190 Shares of Healthpeak Properties, Inc. $DOC

Healthpeak Properties logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Nisa Investment Advisors LLC cut its stake in Healthpeak Properties (NYSE: DOC) by 46.7%, selling 85,190 shares in Q4 and leaving 97,167 shares valued at about $1.56 million per its 13F filing.
  • Wall Street sentiment is mixed: the consensus rating is "Hold" with an average price target of $19.27 (six Buys, eight Holds), and several recent price-target downgrades and neutral initiations from firms including Citigroup, Evercore and Goldman Sachs.
  • Healthpeak beat quarterly EPS estimates ($0.47 vs. $0.45) with revenue up 3.1% Y/Y, set FY2026 EPS guidance of $1.70–1.74, and pays a monthly dividend that implies a 7.4% yield.
  • Five stocks we like better than Healthpeak Properties.

Nisa Investment Advisors LLC reduced its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 46.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 97,167 shares of the real estate investment trust's stock after selling 85,190 shares during the period. Nisa Investment Advisors LLC's holdings in Healthpeak Properties were worth $1,562,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the business. CoreCap Advisors LLC increased its holdings in Healthpeak Properties by 22.4% during the 3rd quarter. CoreCap Advisors LLC now owns 3,352 shares of the real estate investment trust's stock worth $64,000 after acquiring an additional 613 shares during the period. Fiduciary Trust Co boosted its holdings in Healthpeak Properties by 4.9% in the 3rd quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust's stock valued at $264,000 after purchasing an additional 644 shares during the period. Arjuna Capital grew its position in shares of Healthpeak Properties by 4.8% during the 3rd quarter. Arjuna Capital now owns 14,768 shares of the real estate investment trust's stock valued at $283,000 after purchasing an additional 679 shares in the last quarter. Venture Visionary Partners LLC increased its holdings in shares of Healthpeak Properties by 4.8% in the third quarter. Venture Visionary Partners LLC now owns 15,455 shares of the real estate investment trust's stock worth $296,000 after purchasing an additional 703 shares during the period. Finally, Quadrant Capital Group LLC increased its holdings in shares of Healthpeak Properties by 1.9% in the third quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust's stock worth $721,000 after purchasing an additional 718 shares during the period. 93.57% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on DOC shares. Citigroup dropped their price objective on Healthpeak Properties from $18.00 to $17.50 and set a "neutral" rating for the company in a research note on Wednesday. Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a research note on Monday, January 5th. Evercore lowered their price target on Healthpeak Properties from $21.00 to $19.00 and set an "outperform" rating on the stock in a report on Wednesday, February 4th. The Goldman Sachs Group began coverage on Healthpeak Properties in a research report on Friday, January 9th. They set a "neutral" rating and a $17.00 price target for the company. Finally, Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Saturday, March 28th. Six research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $19.27.

Read Our Latest Stock Analysis on DOC

Healthpeak Properties Stock Performance

NYSE DOC opened at $16.53 on Friday. Healthpeak Properties, Inc. has a 52-week low of $15.71 and a 52-week high of $20.10. The company has a fifty day moving average of $17.07 and a 200-day moving average of $17.45. The company has a market capitalization of $11.49 billion, a P/E ratio of 165.27, a P/E/G ratio of 8.84 and a beta of 1.10. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The business had revenue of $719.40 million for the quarter, compared to analysts' expectations of $685.14 million. During the same quarter in the prior year, the firm earned $0.46 earnings per share. The firm's revenue was up 3.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, equities research analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently disclosed a monthly dividend, which was paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th were issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 7.4%. The ex-dividend date of this dividend was Tuesday, March 17th. Healthpeak Properties's dividend payout ratio (DPR) is currently 1,220.00%.

About Healthpeak Properties

(Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Further Reading

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines